Patents Assigned to Pharma Design Inc.
  • Patent number: 8466290
    Abstract: The present invention provides a STATS inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and R1 to R8 and R34 each represent H, halogen, alkyl, phenyl, furyl, thienyl, or the like), or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: June 18, 2013
    Assignees: Pharma IP General Incorporated Association, Pharma Design, Inc., Shizuoka Prefecture, Kumamoto Health Science University, Kabushiki Kaisha Yakult Honsha
    Inventors: Akira Asai, Kenji Matsuno, Naohisa Ogo, Takane Yokotagawa, Osamu Takahashi, Yasuto Akiyama, Tadashi Ashizawa, Tadashi Okawara
  • Publication number: 20120302524
    Abstract: Provided is a 1,3,4-oxadiazole-2-carboxamide compound which has STAT3 inhibitory activity and is useful as an anticancer agent. Provided is a 1,3,4-oxadiazole-2-carboxamide compound represented by formula (I) or a pharmacologically acceptable salt thereof (in the formula, Ar represents a furyl group or the like; R1 represents a hydrogen atom or the like; and —X—Y represents a diaryl group such as a biphenyl group).
    Type: Application
    Filed: December 28, 2010
    Publication date: November 29, 2012
    Applicants: GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION, PHARMA DESIGN, INC., KABUSHIKI KAISHA YAKULT HONSHA, KUMAMOTO HEALTH SCIENCE UNIVERSITY, SHIZUOKA PREFECTURE
    Inventors: Akira Asai, Kenji Matsuno, Naohisa Ogo, Osamu Takahashi, Yoshiaki Masuda, Ayumu Muroya, Yasuto Akiyama, Tadashi Ashizawa, Tadashi Okawara
  • Publication number: 20110172429
    Abstract: The present invention provides a STATS inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and R1 to R8 and R34 each represent H, halogen, alkyl, phenyl, furyl, thienyl, or the like.), or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: July 10, 2009
    Publication date: July 14, 2011
    Applicants: PHARMA IP GENERAL INCORPORATED ASSOCIATION, PHARMA DESIGN, INC., SHIZUOKA PREFECTURE, KUMAMOTO HEALTH SCIENCE UNIVERSITY, KABUSHIKI KAISHA YAKULT HONSHA
    Inventors: Akira Asai, Kenji Matsuno, Naohisa Ogo, Takane Yokotagawa, Osamu Takahashi, Yasuto Akiyama, Tadashi Ashizawa, Tadashi Okawara
  • Patent number: 6932186
    Abstract: A light transmitting device for attachment to a stethoscope headpiece which provides for reversible engagement of the device to the headpiece so that the same can be removed such as for repairs or replacement of batteries. The transmitting device provides a source of light without interfering with the operation of the stethoscope and can be provided without retooling the stethoscope to accommodate a source of light.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: August 23, 2005
    Assignee: Pharma Design Inc
    Inventors: Richard Costa, Hung Mach, Matthew T. Coe
  • Patent number: 6065474
    Abstract: A compliance ring for indicating into which nostril medication has last been sprayed, comprises fixed and movable rings engaged to each other and held between the actuator and the reservoir bottle of the dispenser of the medication. The fixed ring has a cylindrical skirt which is interrupted by a rectangular recess and a movable ring has an outwardly projecting indicator which, with rotation of the movable ring in the fixed ring, moves from one position to the other. In one position, the indicator registers with the letter "R" on the upper surface of the fixed ring, and in the opposition position, the indicator registers with the letter "L". The letters "L" and "R" indicate left and right nostrils which have received medication or are meant to receive medication next.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: May 23, 2000
    Assignee: Pharma Design, Inc.
    Inventor: Matthew Coe
  • Patent number: D436172
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: January 9, 2001
    Assignee: Pharma Design Inc.
    Inventors: Matthew Coe, Kun-Chi Wu
  • Patent number: D508164
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: August 9, 2005
    Assignee: Pharma Design Inc
    Inventors: Matthew Coe, Kun-Chi Wu
  • Patent number: D347136
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: May 24, 1994
    Assignee: Pharma Design, Inc.
    Inventor: Richard Costa
  • Patent number: D406046
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: February 23, 1999
    Assignee: Pharma Design, Inc
    Inventor: Matthew Coe
  • Patent number: D408567
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: April 20, 1999
    Assignee: Pharma Design, Inc.
    Inventor: Matthew Coe